These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21151895)

  • 21. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
    Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
    Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
    Ishiguro M; Hara H
    Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
    Wei CC; Kong YY; Hua X; Li GQ; Zheng SL; Cheng MH; Wang P; Miao CY
    Br J Pharmacol; 2017 Nov; 174(21):3823-3836. PubMed ID: 28812311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphodiesterase III inhibitor cilostazol ameliorates ethanolinduced endothelial dysfunction.
    Takagi T; Mishiro K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Curr Neurovasc Res; 2014; 11(4):302-11. PubMed ID: 25219661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia.
    Hamann GF; Burggraf D; Martens HK; Liebetrau M; Jäger G; Wunderlich N; DeGeorgia M; Krieger DW
    Stroke; 2004 Mar; 35(3):764-9. PubMed ID: 14976330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Description of a Novel Phosphodiesterase (PDE)-3 Inhibitor Protecting Mice From Ischemic Stroke Independent From Platelet Function.
    Bieber M; Schuhmann MK; Volz J; Kumar GJ; Vaidya JR; Nieswandt B; Pham M; Stoll G; Kleinschnitz C; Kraft P
    Stroke; 2019 Feb; 50(2):478-486. PubMed ID: 30566040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke.
    Mao L; Li P; Zhu W; Cai W; Liu Z; Wang Y; Luo W; Stetler RA; Leak RK; Yu W; Gao Y; Chen J; Chen G; Hu X
    Brain; 2017 Jul; 140(7):1914-1931. PubMed ID: 28535201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
    García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I
    Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia.
    Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S
    Brain Res; 2015 Mar; 1602():53-61. PubMed ID: 25617822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone.
    Nonaka Y; Koumura A; Hyakkoku K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):13-22. PubMed ID: 19336663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
    J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.
    Kim YR; Kim HN; Hong KW; Shin HK; Choi BT
    Psychopharmacology (Berl); 2016 Mar; 233(6):1055-66. PubMed ID: 26686236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phosphodiesterase III inhibitor cilostazol protects the brain microvasculature from collagenase injury.
    Imai T; Matsukawa H; Takagi T; Tsuruma K; Shimazawa M; Hara H
    Neuroreport; 2017 Jul; 28(10):555-560. PubMed ID: 28574925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.